In this issue:
Tanezumab vs. NSAIDs for hip or knee OA
Tofacitinib for AS
Progressive exercise vs. best practice advice ±corticosteroid injection for rotator cuff disorders
Continuing vs. withdrawing ixekizumab for axial spondyloarthritis in remission
Tofacitinib and baricitinib in real-world RA patients
Abelacimab for venous thromboembolism prevention
Effect of serum urate lowering with allopurinol on BP in young adults
Tocilizumab prevents systemic sclerosis-associated ILD progression
Inflammatory joint disease morbidity/mortality: impact of COVID-19
FMT for active peripheral PsA
Please login below to download this issue (PDF)